Rithm (RITM) Q2 2025 Earnings Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy RITM?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RITM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RITM
Wall Street analysts forecast RITM stock price to rise
6 Analyst Rating
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.780
Low
14.00
Averages
14.92
High
16.00
Current: 9.780
Low
14.00
Averages
14.92
High
16.00
About RITM
Rithm Capital Corp. is a global asset manager focused on real estate, credit and financial services. The Company makes direct investments and operates several wholly-owned operating businesses. Its segments include Origination and Servicing, Investment Portfolio, Residential Transitional Lending and Asset Management. The Company's businesses include Sculptor Capital Management, Inc., an alternative asset manager, as well as Newrez LLC and Genesis Capital LLC, mortgage origination and servicing platforms. Sculptor Capital Management, Inc. provides asset management services and investment products across credit, real estate and multi-strategy platforms through commingled funds, separate accounts and other alternative investment vehicles. Genesis Capital LLC specializes in originating and managing a portfolio of primarily short-term business purpose mortgage loans to fund single-family and multi-family real estate developers with construction, renovation and bridge loans.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Knoa Pharma Establishes New Board to Enhance Public Health Initiatives
- Company Formation Background: Knoa Pharma LLC begins operations independently on May 1, 2026, aiming to ensure safe access to critical medicines while addressing the opioid crisis and enhancing public health, marking a new chapter following Purdue Pharma's bankruptcy.
- Innovative Governance Structure: Knoa Pharma is 100% owned by the newly established non-profit Knoa Foundation, which has created two independent boards to ensure strong oversight and accountability in drug production and distribution, thereby enhancing public trust.
- Commitment to Public Health: Knoa Pharma will manufacture existing medicines, including opioid analgesics, safely and responsibly without promoting opioid products, operating under a strict injunction to minimize the risk of drug diversion and support the U.S. response to the opioid crisis.
- Leadership Team Composition: The new board comprises leaders with extensive experience in public health, drug policy, and corporate governance, ensuring the company meets critical patient needs while promoting sustainable and transparent operations that enhance social responsibility.
See More
Rithm Capital Dividend History Update
- Dividend Announcement: Rithm Capital Corp recently declared a dividend of $0.4375 per share on its Reset Rate Series D Cumulative Preferred Stock, indicating the company's commitment to maintaining dividend payments, which can enhance investor confidence.
- ETF Composition: According to ETF Finder, Rithm Capital comprises 8.87% of the Simplify Opportunistic Income ETF, highlighting its significance within the fund and potentially attracting more investor interest in the ETF's performance.
- Stock Performance: In Thursday trading, Rithm Capital's Reset Rate Series D Cumulative Preferred Stock rose approximately 0.1%, while common shares increased by about 2.3%, reflecting a positive market response to the company's stock, which may indicate investor optimism about future growth.
- Market Dynamics: Both Rithm Capital's preferred and common stocks performed well during the day, suggesting market recognition of its financial health, which could further drive the company's stock price upward.
See More
Newrez Analysis Reveals Significant Rise in Homeowners Insurance Premiums
- Insurance Premium Growth: An analysis by Newrez of approximately 1.2 million residential mortgage loans reveals that the average annual homeowners insurance premium surged from $1,597 at year-end 2021 to $2,625 at year-end 2025, marking a 64% increase, although the growth rate slowed to 10% in 2025, the lowest since 2021.
- Regional Variations: Arizona experienced the largest increase in insurance premiums from 2021 to 2025 at 94%, while Alaska had the smallest increase at 27%, highlighting significant disparities in insurance costs across different regions.
- Savings Opportunities for Customers: Through a partnership with digital insurtech platform Matic, Newrez customers who switched insurance carriers saved an average of $928, indicating that even amid rising insurance costs, consumers can still find ways to reduce expenses by comparing coverage options.
- Homeowner Resilience: Despite rising insurance costs, overall delinquency rates remain below historical averages, suggesting that homeowners are demonstrating resilience in the face of increasing housing expenses, thereby supporting the long-term stability of household assets.
See More
Rithm (RITM) Q2 2025 Earnings Transcript
See More
Rithm Capital Q1 2026 Earnings Highlights
- Strong Financial Performance: Rithm Capital reported earnings of $0.51 per diluted share and net income of $67.8 million for Q1 2026, demonstrating resilience and profitability amidst market dislocations, which is likely to continue attracting investor interest.
- Robust Market Activity: Management highlighted strong activity levels with over $2 billion in corporate credit deployment and $3 billion in investments during the quarter, indicating the company's capability to capitalize on opportunities in the current market environment.
- Cost Efficiency Improvements: Newrez projects an additional 15% reduction in costs, coupled with annual savings exceeding $65 million, reflecting the company's ongoing efforts to enhance operational efficiency, which will help improve overall profitability.
- Strategic Rebranding Plan: The rebranding of Paramount Group to Elecor Properties and its operational plan aim to drive significant rent growth and occupancy gains in 2026 and beyond, showcasing the company's proactive positioning for future market opportunities.
See More
Rithm Capital Q1 Earnings Exceed Expectations
- Earnings Beat: Rithm Capital reported Q1 non-GAAP EPS of $0.51, surpassing the market expectation of $0.50 but down from $0.74 in the previous quarter, indicating fluctuations in profitability.
- Revenue Growth: The company achieved $1.38 billion in revenue for Q1, exceeding the consensus estimate of $1.27 billion and up from $1.29 billion in the prior quarter, demonstrating resilience in its business amid market challenges.
- Asset Management Expansion: Rithm Asset Management's assets under management reached $59 billion, significantly increasing from $35 billion a year ago, reflecting strong performance in the alternative asset management sector.
- Lending Performance: Genesis Capital recorded origination volume of $1.6 billion, an 80% year-over-year increase, while Newrez generated an annualized operating ROE of 19%, showcasing success in its multichannel mortgage origination business.
See More
Knoa Pharma Establishes New Board to Enhance Public Health Initiatives
- Company Formation Background: Knoa Pharma LLC begins operations independently on May 1, 2026, aiming to ensure safe access to critical medicines while addressing the opioid crisis and enhancing public health, marking a new chapter following Purdue Pharma's bankruptcy.
- Innovative Governance Structure: Knoa Pharma is 100% owned by the newly established non-profit Knoa Foundation, which has created two independent boards to ensure strong oversight and accountability in drug production and distribution, thereby enhancing public trust.
- Commitment to Public Health: Knoa Pharma will manufacture existing medicines, including opioid analgesics, safely and responsibly without promoting opioid products, operating under a strict injunction to minimize the risk of drug diversion and support the U.S. response to the opioid crisis.
- Leadership Team Composition: The new board comprises leaders with extensive experience in public health, drug policy, and corporate governance, ensuring the company meets critical patient needs while promoting sustainable and transparent operations that enhance social responsibility.
See More
Rithm Capital Dividend History Update
- Dividend Announcement: Rithm Capital Corp recently declared a dividend of $0.4375 per share on its Reset Rate Series D Cumulative Preferred Stock, indicating the company's commitment to maintaining dividend payments, which can enhance investor confidence.
- ETF Composition: According to ETF Finder, Rithm Capital comprises 8.87% of the Simplify Opportunistic Income ETF, highlighting its significance within the fund and potentially attracting more investor interest in the ETF's performance.
- Stock Performance: In Thursday trading, Rithm Capital's Reset Rate Series D Cumulative Preferred Stock rose approximately 0.1%, while common shares increased by about 2.3%, reflecting a positive market response to the company's stock, which may indicate investor optimism about future growth.
- Market Dynamics: Both Rithm Capital's preferred and common stocks performed well during the day, suggesting market recognition of its financial health, which could further drive the company's stock price upward.
See More
Newrez Analysis Reveals Significant Rise in Homeowners Insurance Premiums
- Insurance Premium Growth: An analysis by Newrez of approximately 1.2 million residential mortgage loans reveals that the average annual homeowners insurance premium surged from $1,597 at year-end 2021 to $2,625 at year-end 2025, marking a 64% increase, although the growth rate slowed to 10% in 2025, the lowest since 2021.
- Regional Variations: Arizona experienced the largest increase in insurance premiums from 2021 to 2025 at 94%, while Alaska had the smallest increase at 27%, highlighting significant disparities in insurance costs across different regions.
- Savings Opportunities for Customers: Through a partnership with digital insurtech platform Matic, Newrez customers who switched insurance carriers saved an average of $928, indicating that even amid rising insurance costs, consumers can still find ways to reduce expenses by comparing coverage options.
- Homeowner Resilience: Despite rising insurance costs, overall delinquency rates remain below historical averages, suggesting that homeowners are demonstrating resilience in the face of increasing housing expenses, thereby supporting the long-term stability of household assets.
See More
Rithm (RITM) Q2 2025 Earnings Transcript
See More
Rithm Capital Q1 2026 Earnings Highlights
- Strong Financial Performance: Rithm Capital reported earnings of $0.51 per diluted share and net income of $67.8 million for Q1 2026, demonstrating resilience and profitability amidst market dislocations, which is likely to continue attracting investor interest.
- Robust Market Activity: Management highlighted strong activity levels with over $2 billion in corporate credit deployment and $3 billion in investments during the quarter, indicating the company's capability to capitalize on opportunities in the current market environment.
- Cost Efficiency Improvements: Newrez projects an additional 15% reduction in costs, coupled with annual savings exceeding $65 million, reflecting the company's ongoing efforts to enhance operational efficiency, which will help improve overall profitability.
- Strategic Rebranding Plan: The rebranding of Paramount Group to Elecor Properties and its operational plan aim to drive significant rent growth and occupancy gains in 2026 and beyond, showcasing the company's proactive positioning for future market opportunities.
See More
Rithm Capital Q1 Earnings Exceed Expectations
- Earnings Beat: Rithm Capital reported Q1 non-GAAP EPS of $0.51, surpassing the market expectation of $0.50 but down from $0.74 in the previous quarter, indicating fluctuations in profitability.
- Revenue Growth: The company achieved $1.38 billion in revenue for Q1, exceeding the consensus estimate of $1.27 billion and up from $1.29 billion in the prior quarter, demonstrating resilience in its business amid market challenges.
- Asset Management Expansion: Rithm Asset Management's assets under management reached $59 billion, significantly increasing from $35 billion a year ago, reflecting strong performance in the alternative asset management sector.
- Lending Performance: Genesis Capital recorded origination volume of $1.6 billion, an 80% year-over-year increase, while Newrez generated an annualized operating ROE of 19%, showcasing success in its multichannel mortgage origination business.
See More
